Equities

Nurexone Biologic Inc

Nurexone Biologic Inc

Actions
  • Price (EUR)0.382
  • Today's Change-0.014 / -3.54%
  • Shares traded183.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Nurexone Biologic Inc fell by 1.92m. Cash Flow from Financing totalled 1.13m or -- of revenues. In addition the company used 2.94m for operations while cash used for investing totalled 97.00k.
Cash flow per share-0.1058
Price/Cash flow per share--
Book value per share0.052
Tangible book value per share0.052
More ▼

Balance sheet in USDView more

Nurexone Biologic Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.96%.
Current ratio5.10
Quick ratio--
Total debt/total equity0.0097
Total debt/total capital0.0096
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.